table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Precision Cancer Tests Market Size Analysis from 2023 to 2028
1.5.1 Global Precision Cancer Tests Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Precision Cancer Tests Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Precision Cancer Tests Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Precision Cancer Tests Industry Impact
Chapter 2 Global Precision Cancer Tests Competition by Types, Applications, and Top Regions and Countries
2.1 Global Precision Cancer Tests (Volume and Value) by Type
2.1.1 Global Precision Cancer Tests Consumption and Market Share by Type (2017-2022)
2.1.2 Global Precision Cancer Tests Revenue and Market Share by Type (2017-2022)
2.2 Global Precision Cancer Tests (Volume and Value) by Application
2.2.1 Global Precision Cancer Tests Consumption and Market Share by Application (2017-2022)
2.2.2 Global Precision Cancer Tests Revenue and Market Share by Application (2017-2022)
2.3 Global Precision Cancer Tests (Volume and Value) by Regions
2.3.1 Global Precision Cancer Tests Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Precision Cancer Tests Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Precision Cancer Tests Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Precision Cancer Tests Consumption by Regions (2017-2022)
4.2 North America Precision Cancer Tests Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Precision Cancer Tests Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Precision Cancer Tests Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Precision Cancer Tests Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Precision Cancer Tests Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Precision Cancer Tests Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Precision Cancer Tests Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Precision Cancer Tests Sales, Consumption, Export, Import (2017-2022)
4.10 South America Precision Cancer Tests Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Precision Cancer Tests Market Analysis
5.1 North America Precision Cancer Tests Consumption and Value Analysis
5.1.1 North America Precision Cancer Tests Market Under COVID-19
5.2 North America Precision Cancer Tests Consumption Volume by Types
5.3 North America Precision Cancer Tests Consumption Structure by Application
5.4 North America Precision Cancer Tests Consumption by Top Countries
5.4.1 United States Precision Cancer Tests Consumption Volume from 2017 to 2022
5.4.2 Canada Precision Cancer Tests Consumption Volume from 2017 to 2022
5.4.3 Mexico Precision Cancer Tests Consumption Volume from 2017 to 2022
Chapter 6 East Asia Precision Cancer Tests Market Analysis
6.1 East Asia Precision Cancer Tests Consumption and Value Analysis
6.1.1 East Asia Precision Cancer Tests Market Under COVID-19
6.2 East Asia Precision Cancer Tests Consumption Volume by Types
6.3 East Asia Precision Cancer Tests Consumption Structure by Application
6.4 East Asia Precision Cancer Tests Consumption by Top Countries
6.4.1 China Precision Cancer Tests Consumption Volume from 2017 to 2022
6.4.2 Japan Precision Cancer Tests Consumption Volume from 2017 to 2022
6.4.3 South Korea Precision Cancer Tests Consumption Volume from 2017 to 2022
Chapter 7 Europe Precision Cancer Tests Market Analysis
7.1 Europe Precision Cancer Tests Consumption and Value Analysis
7.1.1 Europe Precision Cancer Tests Market Under COVID-19
7.2 Europe Precision Cancer Tests Consumption Volume by Types
7.3 Europe Precision Cancer Tests Consumption Structure by Application
7.4 Europe Precision Cancer Tests Consumption by Top Countries
7.4.1 Germany Precision Cancer Tests Consumption Volume from 2017 to 2022
7.4.2 UK Precision Cancer Tests Consumption Volume from 2017 to 2022
7.4.3 France Precision Cancer Tests Consumption Volume from 2017 to 2022
7.4.4 Italy Precision Cancer Tests Consumption Volume from 2017 to 2022
7.4.5 Russia Precision Cancer Tests Consumption Volume from 2017 to 2022
7.4.6 Spain Precision Cancer Tests Consumption Volume from 2017 to 2022
7.4.7 Netherlands Precision Cancer Tests Consumption Volume from 2017 to 2022
7.4.8 Switzerland Precision Cancer Tests Consumption Volume from 2017 to 2022
7.4.9 Poland Precision Cancer Tests Consumption Volume from 2017 to 2022
Chapter 8 South Asia Precision Cancer Tests Market Analysis
8.1 South Asia Precision Cancer Tests Consumption and Value Analysis
8.1.1 South Asia Precision Cancer Tests Market Under COVID-19
8.2 South Asia Precision Cancer Tests Consumption Volume by Types
8.3 South Asia Precision Cancer Tests Consumption Structure by Application
8.4 South Asia Precision Cancer Tests Consumption by Top Countries
8.4.1 India Precision Cancer Tests Consumption Volume from 2017 to 2022
8.4.2 Pakistan Precision Cancer Tests Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Precision Cancer Tests Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Precision Cancer Tests Market Analysis
9.1 Southeast Asia Precision Cancer Tests Consumption and Value Analysis
9.1.1 Southeast Asia Precision Cancer Tests Market Under COVID-19
9.2 Southeast Asia Precision Cancer Tests Consumption Volume by Types
9.3 Southeast Asia Precision Cancer Tests Consumption Structure by Application
9.4 Southeast Asia Precision Cancer Tests Consumption by Top Countries
9.4.1 Indonesia Precision Cancer Tests Consumption Volume from 2017 to 2022
9.4.2 Thailand Precision Cancer Tests Consumption Volume from 2017 to 2022
9.4.3 Singapore Precision Cancer Tests Consumption Volume from 2017 to 2022
9.4.4 Malaysia Precision Cancer Tests Consumption Volume from 2017 to 2022
9.4.5 Philippines Precision Cancer Tests Consumption Volume from 2017 to 2022
9.4.6 Vietnam Precision Cancer Tests Consumption Volume from 2017 to 2022
9.4.7 Myanmar Precision Cancer Tests Consumption Volume from 2017 to 2022
Chapter 10 Middle East Precision Cancer Tests Market Analysis
10.1 Middle East Precision Cancer Tests Consumption and Value Analysis
10.1.1 Middle East Precision Cancer Tests Market Under COVID-19
10.2 Middle East Precision Cancer Tests Consumption Volume by Types
10.3 Middle East Precision Cancer Tests Consumption Structure by Application
10.4 Middle East Precision Cancer Tests Consumption by Top Countries
10.4.1 Turkey Precision Cancer Tests Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Precision Cancer Tests Consumption Volume from 2017 to 2022
10.4.3 Iran Precision Cancer Tests Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Precision Cancer Tests Consumption Volume from 2017 to 2022
10.4.5 Israel Precision Cancer Tests Consumption Volume from 2017 to 2022
10.4.6 Iraq Precision Cancer Tests Consumption Volume from 2017 to 2022
10.4.7 Qatar Precision Cancer Tests Consumption Volume from 2017 to 2022
10.4.8 Kuwait Precision Cancer Tests Consumption Volume from 2017 to 2022
10.4.9 Oman Precision Cancer Tests Consumption Volume from 2017 to 2022
Chapter 11 Africa Precision Cancer Tests Market Analysis
11.1 Africa Precision Cancer Tests Consumption and Value Analysis
11.1.1 Africa Precision Cancer Tests Market Under COVID-19
11.2 Africa Precision Cancer Tests Consumption Volume by Types
11.3 Africa Precision Cancer Tests Consumption Structure by Application
11.4 Africa Precision Cancer Tests Consumption by Top Countries
11.4.1 Nigeria Precision Cancer Tests Consumption Volume from 2017 to 2022
11.4.2 South Africa Precision Cancer Tests Consumption Volume from 2017 to 2022
11.4.3 Egypt Precision Cancer Tests Consumption Volume from 2017 to 2022
11.4.4 Algeria Precision Cancer Tests Consumption Volume from 2017 to 2022
11.4.5 Morocco Precision Cancer Tests Consumption Volume from 2017 to 2022
Chapter 12 Oceania Precision Cancer Tests Market Analysis
12.1 Oceania Precision Cancer Tests Consumption and Value Analysis
12.2 Oceania Precision Cancer Tests Consumption Volume by Types
12.3 Oceania Precision Cancer Tests Consumption Structure by Application
12.4 Oceania Precision Cancer Tests Consumption by Top Countries
12.4.1 Australia Precision Cancer Tests Consumption Volume from 2017 to 2022
12.4.2 New Zealand Precision Cancer Tests Consumption Volume from 2017 to 2022
Chapter 13 South America Precision Cancer Tests Market Analysis
13.1 South America Precision Cancer Tests Consumption and Value Analysis
13.1.1 South America Precision Cancer Tests Market Under COVID-19
13.2 South America Precision Cancer Tests Consumption Volume by Types
13.3 South America Precision Cancer Tests Consumption Structure by Application
13.4 South America Precision Cancer Tests Consumption Volume by Major Countries
13.4.1 Brazil Precision Cancer Tests Consumption Volume from 2017 to 2022
13.4.2 Argentina Precision Cancer Tests Consumption Volume from 2017 to 2022
13.4.3 Columbia Precision Cancer Tests Consumption Volume from 2017 to 2022
13.4.4 Chile Precision Cancer Tests Consumption Volume from 2017 to 2022
13.4.5 Venezuela Precision Cancer Tests Consumption Volume from 2017 to 2022
13.4.6 Peru Precision Cancer Tests Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Precision Cancer Tests Consumption Volume from 2017 to 2022
13.4.8 Ecuador Precision Cancer Tests Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Precision Cancer Tests Business
14.1 Abbott
14.1.1 Abbott Company Profile
14.1.2 Abbott Precision Cancer Tests Product Specification
14.1.3 Abbott Precision Cancer Tests Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 BD
14.2.1 BD Company Profile
14.2.2 BD Precision Cancer Tests Product Specification
14.2.3 BD Precision Cancer Tests Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Bio-Rad
14.3.1 Bio-Rad Company Profile
14.3.2 Bio-Rad Precision Cancer Tests Product Specification
14.3.3 Bio-Rad Precision Cancer Tests Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Cynvenio Biosystems
14.4.1 Cynvenio Biosystems Company Profile
14.4.2 Cynvenio Biosystems Precision Cancer Tests Product Specification
14.4.3 Cynvenio Biosystems Precision Cancer Tests Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Foundation Medicine
14.5.1 Foundation Medicine Company Profile
14.5.2 Foundation Medicine Precision Cancer Tests Product Specification
14.5.3 Foundation Medicine Precision Cancer Tests Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Genomic Health
14.6.1 Genomic Health Company Profile
14.6.2 Genomic Health Precision Cancer Tests Product Specification
14.6.3 Genomic Health Precision Cancer Tests Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Illumina
14.7.1 Illumina Company Profile
14.7.2 Illumina Precision Cancer Tests Product Specification
14.7.3 Illumina Precision Cancer Tests Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Myriad Genetics
14.8.1 Myriad Genetics Company Profile
14.8.2 Myriad Genetics Precision Cancer Tests Product Specification
14.8.3 Myriad Genetics Precision Cancer Tests Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 NanoString Technologies
14.9.1 NanoString Technologies Company Profile
14.9.2 NanoString Technologies Precision Cancer Tests Product Specification
14.9.3 NanoString Technologies Precision Cancer Tests Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 QIAGEN
14.10.1 QIAGEN Company Profile
14.10.2 QIAGEN Precision Cancer Tests Product Specification
14.10.3 QIAGEN Precision Cancer Tests Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Randox Laboratories
14.11.1 Randox Laboratories Company Profile
14.11.2 Randox Laboratories Precision Cancer Tests Product Specification
14.11.3 Randox Laboratories Precision Cancer Tests Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Roche
14.12.1 Roche Company Profile
14.12.2 Roche Precision Cancer Tests Product Specification
14.12.3 Roche Precision Cancer Tests Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Philips
14.13.1 Philips Company Profile
14.13.2 Philips Precision Cancer Tests Product Specification
14.13.3 Philips Precision Cancer Tests Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Thermo Fisher Scientific
14.14.1 Thermo Fisher Scientific Company Profile
14.14.2 Thermo Fisher Scientific Precision Cancer Tests Product Specification
14.14.3 Thermo Fisher Scientific Precision Cancer Tests Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Precision Cancer Tests Market Forecast (2023-2028)
15.1 Global Precision Cancer Tests Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Precision Cancer Tests Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Precision Cancer Tests Value and Growth Rate Forecast (2023-2028)
15.2 Global Precision Cancer Tests Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Precision Cancer Tests Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Precision Cancer Tests Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Precision Cancer Tests Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Precision Cancer Tests Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Precision Cancer Tests Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Precision Cancer Tests Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Precision Cancer Tests Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Precision Cancer Tests Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Precision Cancer Tests Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Precision Cancer Tests Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Precision Cancer Tests Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Precision Cancer Tests Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Precision Cancer Tests Consumption Forecast by Type (2023-2028)
15.3.2 Global Precision Cancer Tests Revenue Forecast by Type (2023-2028)
15.3.3 Global Precision Cancer Tests Price Forecast by Type (2023-2028)
15.4 Global Precision Cancer Tests Consumption Volume Forecast by Application (2023-2028)
15.5 Precision Cancer Tests Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
